ALSO NOTED: Orchid, Mayne ink marketing deal; Gentium to raise funds; Mylan gets OK for generic Norvasc; and much more...

> India's Orchid Chemicals and Australia's Mayne Pharma have inked a marketing deal for injectable antibiotics. Report [1]

> Italy's Gentium plans to raise $10.9 million through a private placement. Report [2]

> Mylan Laboratories says it has received final approval for a generic version of Pfizer's Norvasc. Article [3]

And Finally… The FDA is planning a two-day meeting in December to review how it handles drug safety alerts. Article [4]